Cargando…

Statement concerning the review of the approval of the active substance ipconazole

In October 2021, the European Commission asked EFSA to provide scientific and technical assistance in accordance with Article 21(2) of Regulation (EC) No 1107/2009 and to deliver a statement on the information submitted by the applicant taking into consideration the assessment of the rapporteur Memb...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412245/ https://www.ncbi.nlm.nih.gov/pubmed/36052015 http://dx.doi.org/10.2903/j.efsa.2022.7133

Ejemplares similares

Statement concerning the review of the approval of the active substance pirimicarb
Publicado: (2023)

Statement concerning the testing strategy and timelines proposed by the applicant for the assessment of the endocrine disruption properties of acibenzolar‐S‐methyl in the context of the review of the approval of the active substance
Publicado: (2023)

Statement concerning the assessment of environmental fate and behaviour and ecotoxicology in the context of the pesticides peer review of the active substance dimoxystrobin
Publicado: (2022)

Statement on the active substance flupyradifurone
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Statement on the active substance acetamiprid
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Updated peer review concerning the risk to mammals and bees for the active substance indoxacarb
Publicado: (2019)

Statement on the impact of the harmonised classification on the conclusion on the peer review of the pesticide risk assessment of the active substance flutianil
Publicado: (2018)

Statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos
Publicado: (2019)

Statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos‐methyl
Publicado: (2019)

Updated statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos‐methyl
Publicado: (2019)

Statement on the relevance of the groundwater metabolite RH‐2651 in the assessment of confirmatory data on the active substance tebufenozide
Publicado: (2021)

Updated risk assessment concerning the risk to wild mammals for the active substance gamma‐cyhalothrin
Publicado: (2021)

Statement of the PPR Panel on a framework for conducting the environmental exposure and risk assessment for transition metals when used as active substances in plant protection products (PPP)
por: Hernandez‐Jerez, Antonio, et al.
Publicado: (2021)

Statement on the safety of d‐ribose
por: Turck, Dominique, et al.
Publicado: (2018)

ESR Statement on the Validation of Imaging Biomarkers
Publicado: (2020)

ESR statement on portable ultrasound devices
Publicado: (2019)

Statement on non‐dietary exposure on diquat
Publicado: (2018)

Statement on risk mitigation measures on cypermethrin
Publicado: (2019)

ESR statement on the stepwise development of imaging biomarkers
Publicado: (2013)

ESR statement on good scientific practice and publishing
Publicado: (2012)

Position Statement on Indications of Echocardiography in Adults - 2019
por: Barberato, Silvio Henrique, et al.
Publicado: (2019)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Scientific statement on the maximum residue levels for potassium phosphonates
Publicado: (2022)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

ESR statement on new approaches to undergraduate teaching in Radiology
Publicado: (2019)

Statement on the BfR opinion regarding the toxicity of 2‐chloroethanol
por: Borroto, Jorge, et al.
Publicado: (2022)

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
por: Turck, Dominique, et al.
Publicado: (2022)

European Commission guidelines on clinical audit. Statement by the European Society of Radiology
Publicado: (2011)

Statement on how to interpret the QPS qualification on ‘acquired antimicrobial resistance genes’
por: Koutsoumanis, Konstantinos, et al.
Publicado: (2023)

Attracting the next generation of radiologists: a statement by the European Society of Radiology (ESR)
Publicado: (2022)

ESR statement on radiation protection: globalisation, personalised medicine and safety (the GPS approach)
Publicado: (2013)

Scientific statement on the coverage of bats by the current pesticide risk assessment for birds and mammals
por: Hernández‐Jerez, Antonio, et al.
Publicado: (2019)

Statement on the revised targeted risk assessment for certain maximum residue levels for nicotine
Publicado: (2023)

Vascular Ultrasound Statement from the Department of Cardiovascular Imaging of the Brazilian Society of Cardiology - 2019
por: dos Santos, Simone Nascimento, et al.
Publicado: (2019)

Ethics of artificial intelligence in radiology: summary of the joint European and North American multisociety statement
por: Geis, J. Raymond, et al.
Publicado: (2019)

Statement on the derivation of Health‐Based Guidance Values (HBGVs) for regulated products that are also nutrients
por: More, Simon, et al.
Publicado: (2021)

Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee
por: Abola, Maria Teresa B, et al.
Publicado: (2020)

Pesticide active substances that do not require a review of the existing maximum residue levels under Article 12 of Regulation (EC) No 396/2005
Publicado: (2022)

Pesticide active substances that do not require a review of the existing maximum residue levels under Article 12 of Regulation (EC) No 396/2005
Publicado: (2017)

Pesticide active substances that do not require a review of the existing maximum residue levels under Article 12 of Regulation (EC) No 396/2005
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fam4in6iqhtvapb8vr6deal2ur